Related Experiment Video
Updated: Mar 8, 2026
12:03
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
Published on: December 9, 2016
13.0K
Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy.
Rosa Simona Pinca1, Maria Cristina Manara1, Valentina Chiadini1
1CRS Development of Biomolecular Therapies, Experimental Oncology Laboratory, Rizzoli Orthopedic Institute, I-40136 Bologna, Italy.
Oncology Reports
|January 24, 2017
Summary
ROCK2 kinase inhibition significantly reduces Ewing sarcoma cell migration and growth. Targeting ROCK2 offers a promising therapeutic strategy for treating metastatic Ewing sarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Ewing sarcoma (EWS) cell migration is critical for metastasis.
- ROCK kinases are implicated in invasion and metastasis in other cancers.
- The role of ROCK in EWS remains under-investigated.
Purpose of the Study:
- To investigate the role of ROCK1 and ROCK2 in EWS cell migration, growth, and differentiation.
- To evaluate the therapeutic potential of ROCK inhibitors in EWS.
Main Methods:
- Western blotting to analyze ROCK1 and ROCK2 expression in EWS cell lines.
- In vitro assays assessing cell migration, growth, and differentiation.
- Treatment with ROCK2-specific and pan-ROCK inhibitors.
Main Results:
- ROCK2 expression correlated with EWS cell migration and anchorage-independent growth.
- ROCK inhibitors reduced EWS cell migration and growth.
- Inhibition of ROCK2 activity showed more pronounced effects on differentiation and morphology changes.
Conclusions:
- ROCK2, not ROCK1, is associated with EWS malignancy.
- ROCK2 is a potential therapeutic target for Ewing sarcoma treatment.
- Targeting ROCK2 may inhibit EWS metastasis and promote differentiation.
Related Concept Videos
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:38Mitogens and the Cell Cycle
8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
01:03Rous Sarcoma Virus (RSV) and Cancer
6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.5K